22-46308730-C-G
Variant names:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_016426.7(GTSE1):āc.549C>Gā(p.Leu183Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00154 in 1,613,526 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.0011 ( 1 hom., cov: 33)
Exomes š: 0.0016 ( 12 hom. )
Consequence
GTSE1
NM_016426.7 synonymous
NM_016426.7 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.668
Genes affected
GTSE1 (HGNC:13698): (G2 and S-phase expressed 1) The protein encoded by this gene is only expressed in the S and G2 phases of the cell cycle, where it colocalizes with cytoplasmic tubulin and microtubules. In response to DNA damage, the encoded protein accumulates in the nucleus and binds the tumor suppressor protein p53, shuttling it out of the nucleus and repressing its ability to induce apoptosis. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 22-46308730-C-G is Benign according to our data. Variant chr22-46308730-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 707839.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.668 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 12 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GTSE1 | NM_016426.7 | c.549C>G | p.Leu183Leu | synonymous_variant | Exon 4 of 12 | ENST00000454366.2 | NP_057510.5 | |
GTSE1 | XM_047441391.1 | c.549C>G | p.Leu183Leu | synonymous_variant | Exon 3 of 11 | XP_047297347.1 | ||
GTSE1 | XM_047441392.1 | c.549C>G | p.Leu183Leu | synonymous_variant | Exon 4 of 10 | XP_047297348.1 | ||
GTSE1 | XR_007067974.1 | n.632C>G | non_coding_transcript_exon_variant | Exon 4 of 9 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00116 AC: 176AN: 152280Hom.: 1 Cov.: 33
GnomAD3 genomes
AF:
AC:
176
AN:
152280
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00185 AC: 459AN: 247810Hom.: 2 AF XY: 0.00216 AC XY: 291AN XY: 134680
GnomAD3 exomes
AF:
AC:
459
AN:
247810
Hom.:
AF XY:
AC XY:
291
AN XY:
134680
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00158 AC: 2305AN: 1461128Hom.: 12 Cov.: 33 AF XY: 0.00179 AC XY: 1303AN XY: 726830
GnomAD4 exome
AF:
AC:
2305
AN:
1461128
Hom.:
Cov.:
33
AF XY:
AC XY:
1303
AN XY:
726830
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00115 AC: 175AN: 152398Hom.: 1 Cov.: 33 AF XY: 0.00117 AC XY: 87AN XY: 74524
GnomAD4 genome
AF:
AC:
175
AN:
152398
Hom.:
Cov.:
33
AF XY:
AC XY:
87
AN XY:
74524
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
7
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Nov 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
GTSE1: BP4, BP7, BS2 -
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Aug 11, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at